Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp
|ClinicalTrials.gov Identifier: NCT00881868|
Recruitment Status : Completed
First Posted : April 15, 2009
Results First Posted : December 23, 2010
Last Update Posted : October 2, 2012
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Triple (Participant, Investigator, Outcomes Assessor); Primary Purpose: Treatment|
Drug: clobetasol propionate spray 0.05%
Drug: Vehicle spray
Dates of recruitment period: First subject was enrolled on April 20, 2009 and the last subject was enrolled on November 17, 2009.
Types of location: Investigative sites were located at private physician offices.
|Pre-assignment Details||Wash-out period to baseline: 14 days: chemical hair process, steroid medication and/or ultraviolet B (UVB) treatment, calcipotriene, other vitamin D analogs, Anthralin/tar, all other anti-psoriasis medications; 4 wks: psoralen & UVA (PUVA) treatment & treatments other than biologics with possible efficacy on psoriasis; 12 wks: biological therapies|